Hitachi LABOSPECT 008에서의 Wako 및 Sekisui 임상화학시약의 분석성능 = Analytical Performance of Wako and Sekisui Clinical Chemistry Assays on Hitachi LABOSPECT 008

다국어 초록 (Multilingual Abstract)

Background: We evaluated the analytical performance of Wako assays for albumin, alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), complement C3 and C4, calcium, creatine kinase (CK), C-reactive protein (CRP), direct bilirubin (DBIL), iron, gamma-glutamyl transferase (GGT), HDL cholesterol (HDLC), inorganic phosphorus (IP), LDL cholesterol (LDLC), total bilirubin (TBIL), total protein (TP),and uric acid (UA), as well as the performance of Sekisui assays for albumin, BUN, calcium, CRP, HDLC, IP, LDLC, TP, and UA by using Hitachi LABOSPECT 008 (Hitachi High-Tech Co., Japan).
Methods: Liquid Assayed Multiqual Control (Bio-Rad Laboratories, USA) and pooled patients’ sera were analyzed for 20 days. Wako linearity material (Wako Pure Chemical Industries, Ltd., Japan) and Sysmex Interference Check A Plus kit (Sysmex Co., Japan) were used to test linearity and interference,respectively. Concentrations of the target analytes were measured using Hitachi LABOSPECT 008 in 100 residual patient specimens and compared to those in Pureauto S series reagent (Sekisui Medical, Japan), which were measured using Hitachi 7600 (Hitachi High-Tech Co., Japan).
Results: Total coefficients of variation (CVs) for the tested analytes were 0.91-9.26% in Wako and 1.04-7.46% in Sekisui assays. Linearity was demonstrated up to the highest concentration within the analytical range in all the assays except for Wako albumin and Sekisui TP. Wako and Sekisui albumin, BUN, CRP, HDLC, and LDLC assays, and in Wako C3, C4, calcium, and UA assays showed no interference with the test concentrations used.
All the tested assays, except for Wako AST, LDLC, and TP, and Sekisui calcium and TP, demonstrated comparability with comparative method for at least one medical decision level.
Conclusions: Our study results showed that the analytical performances of Wako and Sekisui chemistry assays evaluated using Hitachi LABOSPECT 008 had appropriate analytical performance for clinical use

참고문헌 (Reference)

1 강소영, "측정 범위가 넓은 C-Reactive Protein 검사법 비교" 대한진단검사의학회 25 (25): 227-233, 2005

2 Burtis CA, "Tietz textbook of clinical chemistry and molecular diagnostics" Elsevier Saunders 2131-2188, 2011

3 Clinical and Laboratory Standards Institute, "Procedures for the handling and processing of blood specimens for common laboratory tests; approved guideline-Fourth edition, H18-A4"

4 Steen G, "Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays" 44 : 413-419, 2006

5 Clinical and Laboratory Standards Institute, "Method comparison and bias estimation using patient samples; approved guideline-Second edition, EP09-A2"

6 Westgard J., "Medical decision levels"

7 Jacques W, "Interpretation of diagnostic tests" Lippincott Williams & Wilkins 8-30, 2007

8 Clinical and Laboratory Standards Institute, "Interference testing in clinical chemistry, EP07-A2"

9 "Hitachi Clinical Chemistry Analytical Instrument LABOSPECT 008"

10 Clinical and Laboratory Standards Institute, "Evaluation of the linearity of quantitative measurement procedures : a statistical approach; approved guideline, EP06-A"

11 Ji JZ, "Evaluation of the interference of hemoglobin, bilirubin, and lipids on Roche Cobas 6000 assays" 412 : 1550-1553, 2011

12 Clinical and Laboratory Standards Institute, "Evaluation of precision performance of quantitative measurement methods; approved guideline- second edition, EP05-A2"

13 Zivkovic AM, "Effects of sample handling and storage on quantitative lipid analysis in human serum" 5 : 507-516, 2009

14 Westgard J., "Desirable biological variation database specifications"

15 Sisman AR, "Comparison and evaluation of two C-reactive protein assays based on particle-enhanced immunoturbidimetry" 21 : 71-76, 2007